Page 62 - 81_02

57. Lassègue B, Sorescu D, Szöcs K, Yin QQ, Akers M,
Zhang Y, Grant SL, Lambeth JD, Griendling KK.
Novel gp91(phox) homologues in vascular smooth
muscle cells: nox1 mediates angiotensin II-induced
superoxide formation and redox-sensitive signaling
pathways. Circ Res 2001; 88: 888-94.
58. Briones AM, Tabet F, Callera GE, Montezano AC,
Yogi A, He Y, Quinn MT, Salaices M, Touyz RM.
Differential regulation of Nox1, Nox2 and Nox4 in
vascular smooth muscle cells from WKY and SHR. J
Am Soc Hypertens 2011; 5: 137-53.
59. Katsuyama M, Fan C, Arakawa N, Nishinaka T,
Miyagishi M, Taira K, Yabe-Nishimura C. Essential
role of ATF-1 in induction of NOX1, a catalytic
subunit of NADPH oxidase: involvement of
mitochondrial respiratory chain. Biochem J 2005;
386(Pt 2): 255-61.
60. Manea A, Tanase LI, Raicu M, Simionescu M.
JAK/STAT Signaling Pathway Regulates Nox1 and
Nox4-Based NADPH Oxidase in Human Aortic
Smooth Muscle Cells. Arterioscler Thromb Vasc Biol
2010a; 30: 105-12.
61. Martín A, Perez-Girón JV, Hernanz R, Palacios R,
Briones AM, Fortuño A, Zalba G, Salaices M, Alonso
MJ. Peroxisome proliferator-activated receptor-?
activation reduces cyclooxygenase-2 expression in
vascular smooth muscle cells from hypertensive rats
by interfering with oxidative stress. J Hypertens 2012;
30: 315-26.
62. Wang P, Tang F, Li R, Zhang H, Chen S, Liu P,
Huang H. Contribution of different Nox homologues
to cardiac remodeling in two-kidney two-clip
renovascular hypertensive rats: effect of valsartan.
Pharmacol Res 2007; 55: 408-17.
63. Nakano D, Kurumazuka D, Nagai Y, Nishiyama A,
Kiso Y, Matsumura Y. Dietary sesamin suppresses
aortic NADPH oxidase in DOCA salt hypertensive
rats. Clin Exp Pharmacol Physiol 2008; 35: 324-6.
64. Martínez-Revelles S, Avendaño MS, García-
Redonodo AB, Alvarez Y, Aguado A, Pérez-Girón
JV, García-Redondo L, Esteban V, Redondo JM,
Alonso MJ, Briones AM, Salaices M. Reciprocal
relationship between reactive oxygen species and
cyclooxygenase-2 and vascular dysfunction in
hypertension. Antioxid Redox Signal 2013; 18: 51-65.
65. Szöcs K, Lassègue B, Sorescu D, Hilenski LL, Valppu
L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD,
Griendling KK. Upregulation of Nox-based NAD(P)H
oxidases in restenosis after carotid injury. Arterioscler
Thromb Vasc Biol 2002; 22: 21-7.
66. Paravicini TM, Gulluyan LM, Dusting GJ, Drummond
GR. Increased NADPH oxidase activity, gp91phox
expression, and endothelium-dependent
vasorelaxation during neointima formation in rabbits.
Circ Res 2002; 91: 54-61.
67. Sorescu D, Weiss D, Lassègue B, Clempus RE,Szocs
K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD,
Vega JD, Taylor WR, Griendling KK. Superoxide
production and expression of nox family proteins in
142
Andrea Aguado et al.
human atherosclerosis. Circulation 2002; 105: 1429-
35.
68. Kalinina N, Agrotis A, Tararak E, Antropova Y,
Kanellakis P, Ilyinskaya O, Quinn MT, Smirnov V,
Bobik A. Cytochrome b558-dependent NAD(P)H
oxidase-phox units in smooth muscle and
macrophages of atherosclerotic lesions. Arterioscler
Thromb Vasc Biol 2002; 22: 2037-43.
69. Bengtsson SH, Gulluyan LM, Dusting GJ, Drummond
GR. Novel isoforms of NADPH oxidase in vascular
physiology and pathophysiology. Clin Exp Pharmacol
Physiol 2003; 30: 849-54.
70. Cevik MO, Katsuyama M, Kanda S, Kaneko T, Iwata
K, Ibi M, Matsuno K, Kakehi T, Cui W, Sasaki M,
Yabe-Nishimura C. The AP-1 site is essential for the
promoter activity of NOX1/NADPH oxidase, a
vascular superoxide-producing enzyme: possible
involvement of the ERK1/2-JunB pathway. Biochem
Biophys Res Commun 2008; 374: 351-5.
71. Manea A, Tanase LI, Raicu M, Simionescu M.
Transcriptional regulation of NADPH oxidase
isoforms, Nox1 and Nox4, by nuclear factor-kappaB
in human aortic smooth muscle cells. Biochem
Biophys Res Commun 2010b; 396: 901-7.
72. Aguado A, Zhenyukh O, Fischer T, Rodríguez C,
Martínez J, Martínez-Revelles S, Aras R, Dixon DA,
Briones AM, Salaices M. Different regulation of
vascular NOX-1 and NOX-4 expressions by
interleukin-1ß and angiotensin II. Frontiers in
Cardiovascular Biology 2014. Barcelona (July 2014).
Cardiovascular Research 07/2014 103 (suppl 1):S131
73. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD,
Griendling KK. Distinct subcellular localizations of
Nox1 and Nox4 in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol 2004; 24: 677-83.
74. Chen K, Kirber MT, Xiao H, Yang Y, Keaney JF Jr.
Regulation of ROS signal transduction by NADPH
oxidase 4 localization. J Cell Biol 2008; 181: 1129-39.
75. Helmcke I, Heumüller S, Tikkanen R, Schröder K,
Brandes RP. Identification of structural elements in
Nox1 and Nox4 controlling localization and activity.
Antioxid Redox Signal 2009; 11: 1279-87.
76. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt
HH, Harrison DG, Griendling KK. Distinct roles of
Nox1 and Nox4 in basal and angiotensin II-stimulated
superoxide and hydrogen peroxide production. Free
Radic Biol Med 2008; 45: 1340-51.
77. Takac I, Schröder K, Zhang L, Lardy B, Anilkumar N,
Lambeth JD, Shah AM, Morel F, and Brandes RP.
The E-loop is involved in hydrogen peroxide
formation by the NADPH oxidase Nox4. J Biol Chem
2011; 286: 13304-13.
78. Mittal M, Roth M, König P, Hofmann S, Dony E,
Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA,
Kwapiszewska G, Kummer W, Klepetko W, Hoda
MA, Fink L, Hänze J, Seeger W, Grimminger F,
Schmidt HH, Weissmann N. Hypoxia-dependent
regulation of nonphagocytic NADPH oxidase subunit
@Real Academia Nacional de Farmacia. Spain